União Europeia - polonês - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - leki stosowane w cukrzycy - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 i 5.

União Europeia - polonês - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

União Europeia - polonês - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - blokada nerwowo-mięśniowa - wszystkie inne produkty terapeutyczne - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

União Europeia - polonês - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - blokada nerwowo-mięśniowa - wszystkie inne produkty terapeutyczne - odwrócenie blokady nerwowo-mięśniowej wywołanej rokuronium lub wekuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

União Europeia - polonês - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degareliks - nowotwory stercza - terapia endokrynologiczna - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

União Europeia - polonês - EMA (European Medicines Agency)

mylan ireland limited - octan abirateronu - nowotwory stercza - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

União Europeia - polonês - EMA (European Medicines Agency)

mallinckrodt pharmaceuticals ireland limited - ludzki fibrynogen, ludzka trombina - hemostaza, chirurgiczna - antykrościeryczne - leczenie wspomagające, gdzie standardowe techniki chirurgiczne są niewystarczające dla poprawy hemostazy. raplixa powinny być używane w połączeniu z zatwierdzonym galaretowata gąbki. raplixa jest wskazany u dorosłych w wieku powyżej 18 lat.

União Europeia - polonês - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

União Europeia - polonês - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - prekursor komórkowy limfoblastyczny białaczka-chłoniak - Środki przeciwnowotworowe - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

União Europeia - polonês - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - preparaty do obturacyjne choroby dróg oddechowych, - lek budesonide / formoterol teva jest wskazany wyłącznie u dorosłych w wieku 18 lat i starszych. asthmabudesonide/fumaranu teva podano w regularnym leczeniu astmy, w których korzystanie z kombinacji (wziewnych kortykosteroidów i długo działających β2 adrenergicznych), właściwe jest:u pacjentów właściwie nie jest kontrolowana wziewnymi kortykosteroidami i "w miarę potrzeby" wziewnych короткодействующих β2 adrainomimetikov. auryn pacjentów już odpowiednio kontrolowane zarówno wziewnych kortykosteroidów i długo działających β2 adrainomimetikov. copdsymptomatic leczenia pacjentów z ciężką pochp (fev1 < 50%, prognozuje normalny) i powtarzające się liczby zaostrzeń, które mają znaczące objawy, bez względu na regularną terapię z długo działające leki rozszerzające oskrzela.